LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
1
87.86 84.90 111 7680 0.0145 0.0421
MN20160318_Q02
E14
MCF 10A-H2B-mCherry Neratinib
1
87.86 84.90 1084 7680 0.1411 0.4798
MN20160318_Q02
E14
MCF 10A-H2B-mCherry Neratinib
1
87.86 84.90 1070 7680 0.1393 0.4768
MN20160318_Q02
J12
MCF 10A-H2B-mCherry Neratinib
1
87.86 84.90 1254 7680 0.1633 0.5133
MN20160318_Q02
J12
MCF 10A-H2B-mCherry Neratinib
1
89.57 84.90 119 7494 0.0159 0.0536
MN20160318_Q02
E14
MCF 10A-H2B-mCherry Neratinib
1
89.57 84.90 1111 7494 0.1482 0.4886
MN20160318_Q02
E14
MCF 10A-H2B-mCherry Neratinib
1
89.57 84.90 983 7494 0.1312 0.4607
MN20160318_Q02
J12
MCF 10A-H2B-mCherry Neratinib
1
89.57 84.90 1198 7494 0.1599 0.5061
MN20160318_Q02
J12
MCF 10A-H2B-mCherry Neratinib
1
91.27 84.90 108 7420 0.0146 0.0380
MN20160318_Q02
E14
MCF 10A-H2B-mCherry Neratinib
1
91.27 84.90 1114 7420 0.1501 0.4905
MN20160318_Q02
E14
MCF 10A-H2B-mCherry Neratinib
1
91.27 84.90 1001 7420 0.1349 0.4660
MN20160318_Q02
J12
MCF 10A-H2B-mCherry Neratinib
1
91.27 84.90 1219 7420 0.1643 0.5115
MN20160318_Q02
J12
MCF 10A-H2B-mCherry Neratinib
1
92.98 84.90 127 7257 0.0175 0.0648
MN20160318_Q02
E14
MCF 10A-H2B-mCherry Neratinib
1
92.98 84.90 1121 7257 0.1545 0.4950
MN20160318_Q02
E14
MCF 10A-H2B-mCherry Neratinib
1
92.98 84.90 1018 7257 0.1403 0.4727
MN20160318_Q02
J12
MCF 10A-H2B-mCherry Neratinib
1
92.98 84.90 1236 7257 0.1703 0.5179
MN20160318_Q02
J12
MCF 10A-H2B-mCherry Neratinib
1
94.68 84.90 121 7000 0.0173 0.0572
MN20160318_Q02
E14
MCF 10A-H2B-mCherry Neratinib
1
94.68 84.90 1244 7000 0.1777 0.5246
MN20160318_Q02
E14
MCF 10A-H2B-mCherry Neratinib
1
94.68 84.90 967 7000 0.1381 0.4655
MN20160318_Q02
J12
MCF 10A-H2B-mCherry Neratinib
1
94.68 84.90 1232 7000 0.1760 0.5223
MN20160318_Q02
J12
MCF 10A-H2B-mCherry Neratinib
3.1623
2.66 84.90 1 285 0.0035 -0.9209
MN20160318_Q02
J14
MCF 10A-H2B-mCherry Neratinib
3.1623
2.66 84.90 750 285 2.6248 2.4705
MN20160318_Q02
J14
MCF 10A-H2B-mCherry Neratinib
3.1623
2.66 84.90 1 285 0.0035 -0.9209
MN20160318_Q02
K04
MCF 10A-H2B-mCherry Neratinib
3.1623
2.66 84.90 781 285 2.7333 2.5517
MN20160318_Q02
K04
MCF 10A-H2B-mCherry Neratinib
3.1623
4.36 84.90 1 322 0.0031 -0.9004
MN20160318_Q02
J14